Nicola Monteforte
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19.
Journal: Circulation
Published: June 06, 2020
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Journal: Journal of the American College of Cardiology
Published: September 06, 2019
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome.
Journal: Journal of the American College of Cardiology
Published: December 17, 2018
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.
Journal: Journal of the American College of Cardiology
Published: October 02, 2017
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
Journal: Journal of the American College of Cardiology
Published: August 21, 2017
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Journal: Journal of the American College of Cardiology
Published: April 06, 2016
Clinical Presentation and Outcome of Brugada Syndrome Diagnosed With the New 2013 Criteria.
Journal: Journal of cardiovascular electrophysiology
Published: November 04, 2015
Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.
Journal: Journal of the American College of Cardiology
Published: September 08, 2015
Novel insight into the natural history of short QT syndrome.
Journal: Journal of the American College of Cardiology
Published: August 01, 2013
Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
Journal: Circulation
Published: April 25, 2012
Last Updated: 09/26/2026